StockWatch
·
Pharmaceuticals
Dividend14 May 2026, 01:24 pm

Caplin Point Labs Declares ₹4 Interim Dividend for FY26

AI Summary

Caplin Point Laboratories Ltd's board approved the audited standalone and consolidated financial results for the year ended March 31, 2026. An interim dividend of ₹4.00 (200%) per equity share with a face value of ₹2 was declared, with May 30, 2026, set as the record date. The board also approved amendments to the Code of Practices and Procedure for Fair Disclosure of Unpublished Price Sensitive Information. The auditors, M/s Brahmayya & Co, issued an unmodified opinion on the financial statements.

Key Highlights

  • Caplin Point declared an interim dividend of ₹4 per share (200%) for FY26.
  • Record date for the interim dividend is set as May 30, 2026.
  • Audited standalone and consolidated financial results for FY26 approved.
  • Auditors issued an unmodified opinion on the financial statements.
  • Amendments to Code of Practices and Procedure for Fair Disclosure approved.